A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index.
This prospective, randomized, controlled study compares the efficiency of 250 microg or 500 microg of recombinant hCG in serum and follicular fluid (FF) levels and pregnancy rates (PR) in women with high body mass index (BMI) (>or=26 kg/m(2)) undergoing assisted reproduction treatment (ART). Treatment outcomes are similar between the two groups.
Kahraman
Semra
S
Istanbul Memorial Hospital, Istanbul, Turkey. skahraman@superonline.com
Karlikaya
Guvenc
G
Kavrut
Mustecep
M
Karagozoglu
Hale
H
D000328:Adult; D015992:Body Mass Index; D006063:Chorionic Gonadotropin / Q000008:administration & dosage* / Q000009:adverse effects / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D015571:Follicular Fluid / Q000737:chemistry / Q000187:drug effects*; D006801:Humans; D009765:Obesity / Q000097:blood* / Q000378:metabolism; D054315:Oocyte Retrieval; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism; D050177:Overweight / Q000097:blood* / Q000378:metabolism; D011247:Pregnancy; D018873:Pregnancy Rate; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D027724:Reproductive Techniques, Assisted; D016896:Treatment Outcome
D006063:Chorionic Gonadotropin; D011994:Recombinant Proteins